Related Experiment Video
Updated: May 17, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
15-year follow-up of recurrent "hypoglycemia" in preterm infants
Win Tin1, Greta Brunskill, Tom Kelly
1Department of Neonatal Medicine, James Cook University Hospital, Middlesbrough, United Kingdom. win.tin@stees.nhs.uk
Insights
Recurrent low blood glucose levels in preterm infants do not appear to cause long-term harm. This study found no significant differences in development or cognitive function in children with early hypoglycemia compared to controls.
Area of Science:
- Neonatal care
- Pediatric neurology
- Developmental pediatrics
Background:
- A 1988 study suggested recurrent hypoglycemia in preterm infants (<1850g) led to impaired development.
- This prior observation lacked replication and its clinical significance remained uncertain.
Purpose of the Study:
- To investigate the long-term neurodevelopmental outcomes of preterm infants with recurrent asymptomatic hypoglycemia.
- To determine if early low blood glucose levels pose a developmental hazard in a contemporary cohort.
Main Methods:
- A cohort of infants born before 32 weeks gestation in the north of England (1990-1991) had daily blood glucose monitoring for 10 days.
- Children with recurrent hypoglycemia (≤2.5 mmol/L on ≥3 days) were compared to matched controls at ages 2 and 15 years.
Main Results:
- No significant differences in physical disability or developmental progress were found at age 2.
- At age 15, psychometric assessments showed nearly identical cognitive function (mean full-scale IQ: 80.7 vs 81.2) between the hypoglycemia group and controls.
- Subgroup analyses with more frequent or lower glucose thresholds did not alter these findings.
Conclusions:
- This study provides no evidence that recurrent low blood glucose levels (≤2.5 mmol/L) in the first 10 days of life are a hazard to preterm infants.
- The findings challenge previous concerns about the long-term impact of asymptomatic neonatal hypoglycemia.
Background:
Observational study of 543 infants who weighed <1850 g, published in 1988 reported seriously impaired motor and cognitive development at 18 months in those with recurrent, asymptomatic hypoglycemia (plasma glucose level ≤2.5 mmol/L on ≥3 days). No study has yet replicated this observation.
Aim:
To quantify disability in a similar cohort of children followed up throughout childhood.
Population:
All children born at <32 weeks' gestation in the north of England in 1990-1991 and had laboratory blood glucose levels measured daily for the first 10 days of life.
Results:
Forty-seven index children of the 566 who survived to 2 years had a blood glucose level of ≤2.5 mmol/L on ≥3 days. All of these children and hypoglycemia-free controls, matched for hospital of care, gestation, and birth weight, were assessed at age 2. No differences in developmental progress or physical disability were detected. The families were seen again when the children were 15 years old, and 38 of the index children (81%) and matched controls agreed to detailed psychometric assessment. Findings in the 2 groups were nearly identical (mean full-scale IQ: 80.7 vs 81.2). Findings in the 21 children with a level of ≤2.5 mmol/L on ≥4 days, 7 children with a level this low on 5 days, and 11 children with a level of <2.0 mmol/L on 3 different days did not alter these conclusions.
Conclusions:
This study found no evidence to support the belief that recurrent low blood glucose levels (≤2.5 mmol/L) in the first 10 days of life usually pose a hazard to preterm infants.
Related Concept Videos
Hypoglycemia and Glucagon
Hypoglycemia
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hyperglycemia
Diabetes Mellitus: Type 2 and Gestational
Hyperosmolar Hyperglycemic State

